Influence of preoperative transarterial chemoembolization on the prognosis for patients with resectable hepatocellular carcinoma: A meta-analysis of randomized trials

Hepato-Gastroenterology

Volumn 58, Issue 107-108, 2011, Pages 869-874

  Wang, Xiaofei ^a   Li, Jingdong ^a   Peng, Yong ^a   Dai, Yi ^a   Xu, Wei ^a  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Hepatocellular carcinoma; Meta analysis; Systematic review; Therapy; Transarterial chemoembolization

Indexed keywords

ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE;

EID: 80051658430     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M: Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224:47-54. (Pubitemid 34680374)
2. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37:429-442.
3. Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Tibballs J, Meyer T, Patch DW, Burroughs AK: Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007; 30:6-25. (Pubitemid 44900485)
4. Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M: The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000; 89:2606-2612. (Pubitemid 32011605)
5. Gerunda GE, Neri D, Merenda R, Barbazza F, Zangrandi F, Meduri F, Bisello M, Valmasoni M, Gangemi A, Faccioli AM: Role of transarterial chemoembolization before liver resection for hepatocarcinoma. Liver Transpl 2000; 6:619-626.
6. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P: Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 1998; 82:1028-1036.
7. Choi GH, Kim DH, Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR: Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma? World J Surg 2007; 31:2370-2377.
8. Kaibori M, Tanigawa N, Matsui Y, Saito T, Uchida Y, Ishizaki M, Tanaka H, Kamiyama Y: Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction. Anticancer Res 2006; 26:3685-3692. (Pubitemid 44701444)
9. Ochiai T, Sonoyama T, Hironaka T, Yamagishi H: Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma. Hepato-gastroenterology 2003; 50:750-755. (Pubitemid 36613398)
10. Lu CD, Peng SY, Jiang XC, Chiba Y, Tanigawa N: Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases. World J Surg 1999; 23:293-300. (Pubitemid 29091700)
11. Uchida M, Kohno H, Kubota H, Hayashi T, Yamanoi A, Kimoto T, Ono T, Nagasue N: Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg 1996; 20:326-331. (Pubitemid 26082685)
12. Sasaki A, Iwashita Y, Shibata K, Ohta M, Kitano S, Mori M: Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol 2006; 32:773-779. (Pubitemid 44276006)
13. Kim IS, Lim YS, Lee HC, Suh DJ, Lee YJ, Lee SG: Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome. Aliment Pharmacol Ther 2008; 27:338-345.
14. Lee KT, Lu YW, Wang SN, Chen HY, Chuang SC, Chang WT, Shi HY, Ker CG, Chiu HC: The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes: J Surg Oncol 2009; 99:343-350.
15. Yamasaki S, Hasegawa H, Kinoshita H, Furukawa M, Imaoka S, Takasaki K, Kakumoto Y, Saitsu H, Yamada R, Oosaki Y, Arii S, Okamoto E, Monden M, Ryu M, Kusano S, Kanematsu T, Ikeda K, Yamamoto M, Saoshiro T, Tsuzuki T: A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 1996; 87:206-211. (Pubitemid 26099497)
16. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, P'eng FK: Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 1995; 82:122-126.
17. Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY, Lau WY, Wu MC: A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009; 249:195-202.
18. Altman DG: Systematic reviews of evaluations of prognostic variables. BMJ 2001; 323:224-228.
19. Hayden JA, Cote P, Bombardier C: Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006; 144:427-437. (Pubitemid 46768164)
20. Parmar MK, Torri V, Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17:2815-2834.
21. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539-1558.
22. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
23. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2001; 2:533-543.
24. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S: Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106:1618-1624.
25. Poon RT, Fan ST, Lo CM, Liu CL, Wong J: Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229:216-222. (Pubitemid 30191795)
26. Nakashima T, Kojiro M: Pathologic characteristics of hepatocellular carcinoma. Semin Liver Dis 1986; 6:259-266.
27. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF: Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13:S211-221.
28. Kobayashi N, Ishii M, Ueno Y, Kisara N, Chida N, Iwasaki T, Toyota T: Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. Liver 1999; 19:25-31. (Pubitemid 29034107)
29. Liou TC, Shih SC, Kao CR, Chou SY, Lin SC, Wang HY: Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization. J Hepatol 1995; 23:563-568.
30. Louha M, Poussin K, Ganne N, Zylberberg H, Nalpas B, Nicolet J, Capron F, Soubrane O, Vons C, Pol S, Beaugrand M, Berthelot P, Franco D, Trinchet JC, Brechot C, Paterlini P: Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 1997; 26:998-1005. (Pubitemid 27413670)